Asymptotic analysis of optimal vaccination policies by Penn, MJ, Donnelly, C

“…Targeted vaccination policies can have a significant impact on the number of infections and deaths in an epidemic. …”

Which vaccine? The cost of religious freedom in vaccination policy by Giubilini, A, Savulescu, J, Wilkinson, D

A panel dataset of COVID-19 vaccination policies in 185 countries by Cameron-Blake, E, Tatlow, H, Andretti, B, Boby, T, Green, K, Hale, T, Petherick, A, Phillips, T, Pott, A, Wade, A, Zha, H

“…We present a panel dataset of COVID-19 vaccine policies, with data from 01 January 2020 for 185 countries and a number of subnational jurisdictions, reporting on vaccination prioritization plans, eligibility and availability, cost to the individual and mandatory vaccination policies. …”

Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy by Britto, CD, Dyson, ZA, Duchene, S, Carter, MJ, Gurung, M, Kelly, DF, Murdoch, DR, Ansari, I, Thorson, S, Shrestha, S, Adhikari, N, Dougan, G, Holt, KE, Pollard, AJ

Developing a framework for public involvement in mathematical and economic modelling: bringing new dynamism to vaccination policy recommendations by Staniszewska, S, Hill, EM, Grant, R, Grove, P, Porter, J, Shiri, T, Tulip, S, Whitehurst, J, Wright, C, Datta, S, Petrou, S, Keeling, M

A focused-protection vaccination strategy: why we should not target children with COVID-19 vaccination policy by Giubilini, A, Gupta, S, Heneghan, C

A spoonful of honey or a gallon of vinegar? A conditional COVID-19 vaccination policy for frontline healthcare workers by Bradfield, O, Giubilini, A

A global database of COVID-19 vaccinations by Mathieu, E, Ritchie, H, Ortiz-Ospina, E, Roser, M, Hasell, J, Appel, C, Giattino, C, Rodés-Guirao, L

“…This resource aids policymakers and researchers in understanding the rate of current and potential vaccine rollout; the interactions with non-vaccination policy responses; the potential impact of vaccinations on pandemic outcomes such as transmission, morbidity and mortality; and global inequalities in vaccine access.…”

The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): A model comparison study by Flasche, S, Jit, M, Rodríguez-Barraquer, I, Coudeville, L, Recker, M, Koelle, K, Milne, G, Hladish, TJ, Perkins, TA, Cummings, DAT, Dorigatti, I, Laydon, DJ, España, G, Kelso, J, Longini, I, Lourenco, J, Pearson, CAB, Reiner, RC, Mier-Y-Terán-Romero, L, Vannice, K, Ferguson, N

“…All models predicted that in settings with moderate to high dengue endemicity (SP9 ≥ 50%), the default vaccination policy would reduce the burden of dengue disease for the population by 6%–25% (all simulations: –3%–34%) and in high-transmission settings (SP9 ≥ 70%) by 13%–25% (all simulations: 10%– 34%). …”

Nudging immunity: the case for vaccinating children in school and day care by default by Giubilini, A, Caviola, L, Maslen, H, al., E

“…In this paper we propose a type of vaccination policy that could be implemented either in addition to coercive vaccination or as an alternative to it in order to increase paediatric vaccination uptake in a non-coercive way. …”

Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study by Osei-Yeboah, R, Johannesen, CK, Egeskov-Cavling, AM, Chen, J, Lehtonen, T, Fornes, AU, Paget, J, Fischer, TK, Wang, X, Nair, H, Campbell, H

“…</p> <p><strong>Conclusions:</strong> This study provides important evidence for identifying risk groups and assisting health authorities in RSV vaccination policy making.</p>…”

Retrospective review of documentation practices of hepatitis B immunoglobulin, birth dose, and vaccination at the hospital of birth, in Thai nationals and migrants in Northern Thai... by Bierhoff, M, Pinyopornpanish, Kanokporn, Pinyopornpanish, Kanokwan, Tongprasert, F, Keereevijit, A, Rijken, M, Chu, CS, Nosten, F, Perfetto, J, van Vugt, M, McGready, R, Angkurawaranon, C

“…</p> <p><strong>Conclusions</strong></p> <p>This review provides strong support for excellent documentation of HBIG and birth dose vaccination in urban and rural settings, and in migrants, consistent with Thailand’s vaccination policy and practice. Documentation of the 3 HBV EPI at the hospital of birth decreases with sequential doses, especially in families further away. …”

The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid... by Carey, ME, MacWright, WR, Im, J, Meiring, JE, Gibani, MM, Park, SE, Longley, A, Jeon, HJ, Hemlock, C, Yu, AT, Soura, A, Aiemjoy, K, Owusu-Dabo, E, Terferi, M, Islam, S, Lunguya, O, Jacobs, J, Gordon, M, Dolecek, C, Baker, S, Pitzer, VE, Yousafzai, MT, Tonks, S, Clemens, JD, Date, K, Qadri, F, Heyderman, RS, Saha, SK, Basnyat, B, Okeke, IN, Qamar, FN, Voysey, M, Luby, S, Kang, G, Andrews, J, Pollard, AJ, John, J, Garrett, D, Marks, F

“…It is important to ensure that lessons learned from these studies not only inform vaccination policy, but also are incorporated into sustainable, low-cost, integrated vaccine-preventable disease surveillance systems.…”

Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries by Voysey, M, Fanshawe, T, Kelly, D, O'Brien, K, Kandasamy, R, Shrestha, S, Thorson, S, Hinds, J, Pollard, A

“…These findings are important for global vaccination policy, to interrupt transmission by protecting against carriage.…”

Factors associated with the opposition to COVID-19 vaccination certificates: a multi-country observational study from Asia by Kc, S, Faradiba, D, Sittimart, M, Isaranuwatchai, W, Ananthakrishnan, A, Rachatan, C, Dabak, S, Shafie, AA, Guerrero, AM, Suwantika, A, Kang, G, Ahn, J, Hsu, LY, Mayxay, M, Howard, N, Wattanasri, P, Nakamura, R, George, TK, Teerawattananon, Y

“…<br><strong> Method<br></strong> The COVID-19 Vaccination Policy Research and Decision-Support Initiative in Asia (CORESIA) was established to address policy questions related to CVCs. …”

Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study by Taylor, JEB, Surey, J, MacLellan, J, Francis, M, Abubakar, I, Stagg, HR

“…Currently, there is a national targeted HBV vaccine policy for such at-risk groups, but there is limited recent evidence about 1) the levels of vaccine uptake, 2) the factors associated with incomplete vaccination, and 3) reasons for incomplete vaccination. …”

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic model... by Brisson, M, Bénard, É, Drolet, M, Bogaards, JA, Baussano, I, Vänskä, S, Jit, M, Boily, M-C, Smith, MA, Berkhof, J, Canfell, K, Chesson, HW, Burger, EA, Choi, YH, De Blasio, BF, De Vlas, SJ, Guzzetta, G, Hontelez, JAC, Horn, J, Jepsen, MR, Kim, JJ, Lazzarato, F, Matthijsse, SM, Mikolajczyk, R, Pavelyev, A, Pillsbury, M, Shafer, LA, Tully, SP, Turner, HC, Usher, C, Walsh, C

“… <h4>Background</h4> <p>Modelling studies have been widely used to inform human papillomavirus (HPV) vaccination policy decisions; however, many models exist and it is not known whether they produce consistent predictions of population-level eff ectiveness and herd eff ects. …”

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England,... by Bedston, S, Almaghrabi, F, Patterson, L, Agrawal, U, Woolford, L, Anand, SN, Joy, M, Crawford, A, Goudie, R, Byford, R, Abbasizanjani, H, Smith, D, Laidlaw, L, Akbari, A, Sullivan, C, Bradley, DT, Lyons, RA, de Lusignan, S, Hobbs, FDR, Robertson, C, Sheikh, SA, Shi, T

“…<strong>Background<br></strong> UK COVID-19 vaccination policy has evolved to offering COVID-19 booster doses to individuals at increased risk of severe Illness from COVID-19. …”

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in Englan... by Agrawal, U, Bedston, S, McCowan, C, Oke, J, Patterson, L, Robertson, C, Akbari, A, Azcoaga-Lorenzo, A, Bradley, DT, Fagbamigbe, AF, Grange, Z, Hall, ECR, Joy, M, Katikireddi, SV, Kerr, S, Ritchie, L, Murphy, S, Owen, RK, Rudan, I, Shah, SA, Simpson, CR, Torabi, F, Tsang, RSM, de Lusignan, S, Lyons, RA, O'Reilly, D, Sheikh, A

“…<p><strong>Background</strong></p> Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of the population could benefit most. …”

Hand, foot, and mouth disease in China: Modeling epidemic dynamics of enterovirus serotypes and implications for vaccination. by Takahashi, S, Liao, Q, Van Boeckel, T, Xing, W, Sun, J, Hsiao, V, Metcalf, C, Chang, Z, Liu, F, Zhang, J, Wu, J, Cowling, B, Leung, G, Farrar, J, van Doorn, H, Grenfell, B, Yu, H

“…To better inform vaccination policy, we used mathematical models to evaluate the effect of prospective vaccination against EV-A71-associated HFMD and the potential risk of serotype replacement by CV-A16. …”